Kromek H1 revenues surge, swings to positive EBITDA performance

(Sharecast News) - Detection company Kromek said on Monday that it expects to report interim revenues of at least £14.5m, up from £3.7m a year earlier, swinging it to a positive first-half adjusted EBITDA performance. Kromek's first-half revenue estimate included revenue generated under its enablement agreement with Siemens Healthineers of at least £8.2m.

However, on an underlying basis, H1 revenues were predicted to be no less than £6.3m, up 70% on the prior year, driven by strong growth in its CBRN Detection division, as well as an increase in underlying revenue in its Advanced Imaging unit.

"As a result of the increase in revenue, along with an expected improvement in gross margin due to the contribution from Siemens Healthineers, the group expects to report profit before tax and positive adjusted EBITDA for the first half of 2026 compared with a loss before tax of £5.7m and an adjusted EBITDA loss of £2.3m for H1 2025," said Kromek.

Kromek added that its H1 trading performance had reinforced the board's confidence that the group will deliver revenue growth for FY26, with results seen in line with market expectations.

As of 1020 GMT, Kromek shares were up 4.68% at 7.59p.





Reporting by Iain Gilbert at Sharecast.com